Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)

NCT04344184 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT04344184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04344184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Completed
Start date
December 18, 2020
Completion date
June 10, 2022
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, kidney injury, lung injury, acute